Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ruth Wu-Wong

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 3, 2002
Using receptor antagonists in binding studies to characterize a mammalian endothelin receptorJ Ruth Wu-Wong
Current Opinion in Investigational Drugs (London, England : 2000)|August 26, 2009
Are vitamin D receptor activators useful for the treatment of thrombosis?J Ruth Wu-Wong
Methods in Molecular Biology (Clifton, N.J.)|August 3, 2002
Characterization of a new endothelin receptor ligand by in vitro assaysJ Ruth Wu-Wong
Current Opinion in Investigational Drugs (London, England : 2000)|August 30, 2008
Endothelial dysfunction and chronic kidney disease: treatment optionsJ Ruth Wu-Wong
Current Opinion in Investigational Drugs (London, England : 2000)|September 5, 2002
Endothelin receptor antagonists as therapeutic agents for cancerJ Ruth Wu-Wong
Current Pharmaceutical Design|June 3, 2011
Vitamin D therapy in cardiac hypertrophy and heart failureJ Ruth Wu-Wong
Current Opinion in Investigational Drugs (London, England : 2000)|August 21, 2002
S-0139 (Shionogi)J Ruth Wu-Wong
Idrugs : the Investigational Drugs Journal|January 5, 2008
American Society of Nephrology--40th Annual Conference (renal week 2007)J Ruth Wu-Wong
Current Opinion in Investigational Drugs (London, England : 2000)|April 6, 2007
Vascular calcification in chronic kidney failure: role of vitamin D receptorJ Ruth Wu-Wong, Joel Melnick
Journal of Vascular Research|December 13, 2006
Vitamin D analogs modulate the expression of plasminogen activator inhibitor-1, thrombospondin-1 and thrombomodulin in human aortic smooth muscle cellsJ Ruth Wu-Wong, Masaki Nakane, Junli Ma
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Methods in Molecular Biology (Clifton, N.J.)|August 3, 2002
Using receptor antagonists in binding studies to characterize a mammalian endothelin receptorJ Ruth Wu-Wong
Current Opinion in Investigational Drugs (London, England : 2000)|August 26, 2009
Are vitamin D receptor activators useful for the treatment of thrombosis?J Ruth Wu-Wong
Methods in Molecular Biology (Clifton, N.J.)|August 3, 2002
Characterization of a new endothelin receptor ligand by in vitro assaysJ Ruth Wu-Wong
Current Opinion in Investigational Drugs (London, England : 2000)|August 30, 2008
Endothelial dysfunction and chronic kidney disease: treatment optionsJ Ruth Wu-Wong
Current Opinion in Investigational Drugs (London, England : 2000)|September 5, 2002
Endothelin receptor antagonists as therapeutic agents for cancerJ Ruth Wu-Wong
Current Pharmaceutical Design|June 3, 2011
Vitamin D therapy in cardiac hypertrophy and heart failureJ Ruth Wu-Wong
Current Opinion in Investigational Drugs (London, England : 2000)|August 21, 2002
S-0139 (Shionogi)J Ruth Wu-Wong
Idrugs : the Investigational Drugs Journal|January 5, 2008
American Society of Nephrology--40th Annual Conference (renal week 2007)J Ruth Wu-Wong
Current Opinion in Investigational Drugs (London, England : 2000)|April 6, 2007
Vascular calcification in chronic kidney failure: role of vitamin D receptorJ Ruth Wu-Wong, Joel Melnick
Journal of Vascular Research|December 13, 2006
Vitamin D analogs modulate the expression of plasminogen activator inhibitor-1, thrombospondin-1 and thrombomodulin in human aortic smooth muscle cellsJ Ruth Wu-Wong, Masaki Nakane, Junli Ma
Pageof 5